MicroCal PEAQ-DSC - The Gold Standard for protein stability characterization

Scientists from the University of Bristol, CNRS and Imophoron Ltd worked with the computer technology giant Oracle to develop a new kind of vaccine that needs no refrigeration. They used synthetic biology, cryo-electron microscopy and high-performance cloud computing to produce a candidate vaccine against the mosquito-borne chikungunya virus. Their findings could revolutionise the way vaccines are designed, developed and stored.

Can we make drugs that not only break/inhibit interactions between a protein and a ligand, but rather bestow new functionality? Nicolas Thomä explores molecular glue drugs, and their potential to make much needed medicines that were previously out of reach.

In this video, we present "Life According to Orbitrap Mass Spec - high resolution why you need it".